Ftse Mib
36.619,08
0,52%
DAX
21.749,12
0,09%
S&P 500
6.071,17
0,53%
NASDAQ
19.681,75
0,25%
Bitcoin
104.070,07
-0,63%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Dr Reddys Laboratories Ltd (RDY) Dr Reddys Laboratories Ltd (RDY) Notizie

Dr Reddys Laboratories Ltd

RDY
13,81
0,00 (0,00%)
31 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/1/202518:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/1/202513:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202519:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202518:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202512:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202512:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202521:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202519:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202518:35BWDr. Reddy’s Q3 & 9MFY25 Financial Results
22/1/202519:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202512:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202513:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202512:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202418:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/12/202419:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/12/202419:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202412:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202413:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202412:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/12/202412:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/12/202412:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202412:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202412:15BWDr. Reddy's launches Toripalimab in India, the first and..
27/11/202414:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202414:07BWDr. Reddy's Laboratories and Senores Pharmaceuticals, Inc...
26/11/202412:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202412:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202412:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202412:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/11/202414:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202413:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202412:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202412:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/11/202420:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/11/202419:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/11/202415:59BWDr. Reddy’s Q2 & H1FY25 Financial Results
04/11/202418:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/10/202415:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/10/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
28/10/202413:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202413:40BWDr. Reddy's Named by Science Magazine in Top 20 Global..
24/10/202422:44EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
23/10/202418:18EDGAR2Form F-6 - Registration of American Depository Receipt..
21/10/202416:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/10/202413:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/10/202415:47BWDr. Reddy’s Launches Comprehensive Menopause Support Program..
10/10/202417:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/10/202417:32BWAurigene Oncology Limited Announces Promising Results of..
08/10/202413:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: Min: Max:
Chiusura: 13,81

La tua Cronologia

NYSE
RDY
Dr Reddys Laboratories
BOV
B1IL34R
Bilibili
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci